| . | Non-adjusted efficacy (%) . | GEE-adjusted efficacy (%) . | P . |
|---|---|---|---|
| Sex | 93.6 | 83.4 | 0.075 |
| Male | 74.4 | 66.1 | |
| Female | |||
| Cardiomyopathy | |||
| CAD | 91.3 | 84.3 | 0.371 |
| DCM | 94.3 | 77.9 | |
| LVEF | |||
| ≤30% | 93.5 | 76.5 | 0.093 |
| >30% | 92.7 | 89.0 | |
| β-Blockers | |||
| Yes | 93.8 | 83.6 | 0.230 |
| No | 89.2 | 75.3 | |
| Amiodarone | |||
| Yes | 85.1 | 77.6 | 0.376 |
| No | 94.0 | 83.1 | |
| Indication of implantation | |||
| Primary | 84.7 | 78.3 | 0.449 |
| Secondary | 93.9 | 82.9 |
| . | Non-adjusted efficacy (%) . | GEE-adjusted efficacy (%) . | P . |
|---|---|---|---|
| Sex | 93.6 | 83.4 | 0.075 |
| Male | 74.4 | 66.1 | |
| Female | |||
| Cardiomyopathy | |||
| CAD | 91.3 | 84.3 | 0.371 |
| DCM | 94.3 | 77.9 | |
| LVEF | |||
| ≤30% | 93.5 | 76.5 | 0.093 |
| >30% | 92.7 | 89.0 | |
| β-Blockers | |||
| Yes | 93.8 | 83.6 | 0.230 |
| No | 89.2 | 75.3 | |
| Amiodarone | |||
| Yes | 85.1 | 77.6 | 0.376 |
| No | 94.0 | 83.1 | |
| Indication of implantation | |||
| Primary | 84.7 | 78.3 | 0.449 |
| Secondary | 93.9 | 82.9 |
CAD, coronary artery disease; CRT-D, cardiac resynchronization therapy; DCM, dilated cardiomyopathy; LVEF, left ventricular ejection fraction.
| . | Non-adjusted efficacy (%) . | GEE-adjusted efficacy (%) . | P . |
|---|---|---|---|
| Sex | 93.6 | 83.4 | 0.075 |
| Male | 74.4 | 66.1 | |
| Female | |||
| Cardiomyopathy | |||
| CAD | 91.3 | 84.3 | 0.371 |
| DCM | 94.3 | 77.9 | |
| LVEF | |||
| ≤30% | 93.5 | 76.5 | 0.093 |
| >30% | 92.7 | 89.0 | |
| β-Blockers | |||
| Yes | 93.8 | 83.6 | 0.230 |
| No | 89.2 | 75.3 | |
| Amiodarone | |||
| Yes | 85.1 | 77.6 | 0.376 |
| No | 94.0 | 83.1 | |
| Indication of implantation | |||
| Primary | 84.7 | 78.3 | 0.449 |
| Secondary | 93.9 | 82.9 |
| . | Non-adjusted efficacy (%) . | GEE-adjusted efficacy (%) . | P . |
|---|---|---|---|
| Sex | 93.6 | 83.4 | 0.075 |
| Male | 74.4 | 66.1 | |
| Female | |||
| Cardiomyopathy | |||
| CAD | 91.3 | 84.3 | 0.371 |
| DCM | 94.3 | 77.9 | |
| LVEF | |||
| ≤30% | 93.5 | 76.5 | 0.093 |
| >30% | 92.7 | 89.0 | |
| β-Blockers | |||
| Yes | 93.8 | 83.6 | 0.230 |
| No | 89.2 | 75.3 | |
| Amiodarone | |||
| Yes | 85.1 | 77.6 | 0.376 |
| No | 94.0 | 83.1 | |
| Indication of implantation | |||
| Primary | 84.7 | 78.3 | 0.449 |
| Secondary | 93.9 | 82.9 |
CAD, coronary artery disease; CRT-D, cardiac resynchronization therapy; DCM, dilated cardiomyopathy; LVEF, left ventricular ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
